{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T16:21:47Z","timestamp":1784132507791,"version":"3.55.0"},"reference-count":50,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T00:00:00Z","timestamp":1661299200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012190","name":"Ministry of Science and Higher Education of the Russian Federation to the EIMB Center for Precision Genome Editing and Genetic Technologies for Biomedicine under the Federal Research Program for Genetic Technologies Development","doi-asserted-by":"publisher","award":["075-15-2019-1660"],"award-info":[{"award-number":["075-15-2019-1660"]}],"id":[{"id":"10.13039\/501100012190","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microorganisms"],"abstract":"<jats:p>Gonococcal infection caused by the Gram-negative bacteria Neisseria gonorrhoeae is one of the most common sexually transmitted infections (STIs) worldwide [...]<\/jats:p>","DOI":"10.3390\/microorganisms10091699","type":"journal-article","created":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T23:48:58Z","timestamp":1661384938000},"page":"1699","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Antibiotic Resistance in Neisseria gonorrhoeae: Challenges in Research and Treatment"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0316-2262","authenticated-orcid":false,"given":"Boris","family":"Shaskolskiy","sequence":"first","affiliation":[{"name":"Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9416-875X","authenticated-orcid":false,"given":"Ilya","family":"Kandinov","sequence":"additional","affiliation":[{"name":"Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Dementieva","sequence":"additional","affiliation":[{"name":"Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3183-318X","authenticated-orcid":false,"given":"Dmitry","family":"Gryadunov","sequence":"additional","affiliation":[{"name":"Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,8,24]]},"reference":[{"key":"ref_1","unstructured":"WHO (World Health Organization) (2016). WHO Guidelines for the Treatment of Neisseria Gonorrhoeae, WHO."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1093\/cid\/ciac043","article-title":"Management of Neisseria gonorrhoeae in the United States: Summary of Evidence From the Development of the 2020 Gonorrhea Treatment Recommendations and the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infection Treatment Guidelines","volume":"74","author":"Barbee","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.15585\/mmwr.mm6950a6","article-title":"Update to CDC\u2019s Treatment Guidelines for Gonococcal Infection, 2020","volume":"69","author":"Barbee","year":"2020","journal-title":"MMWR. Morb. Mortal. Wkly. Rep."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1177\/0956462420948739","article-title":"Background review for the \u20182020 European guideline for the diagnosis and treatment of gonorrhoea in adults\u2019","volume":"32","author":"Unemo","year":"2021","journal-title":"Int. J. STD AIDS"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00430-019-00651-4","article-title":"Multiresistant Neisseria gonorrhoeae: A New Threat in Second Decade of the XXI Century","volume":"209","author":"Majewska","year":"2020","journal-title":"Med. Microbiol. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Golparian, D., Harris, S.R., S\u00e1nchez-Bus\u00f3, L., Hoffmann, S., Shafer, W.M., Bentley, S.D., Jensen, J.S., and Unemo, M. (2020). Genomic evolution of Neisseria gonorrhoeae since the preantibiotic era (1928\u20132013): Antimicrobial use\/misuse selects for resistance and drives evolution. BMC Genom., 21.","DOI":"10.1186\/s12864-020-6511-6"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1800617","DOI":"10.2807\/1560-7917.ES.2018.23.47.1800617","article-title":"Multidrug-resistant Neisseria gonorrhoeae isolate, belonging to the internationally spreading Japanese FC428 clone, with ceftriaxone resistance and intermediate resistance to azithromycin, Ireland, August 2018","volume":"23","author":"Golparian","year":"2018","journal-title":"Eurosurveillance"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3201\/eid1701.100397","article-title":"Ceftriaxone-resistant Neisseria gonorrhoeae, Japan","volume":"17","author":"Ohnishi","year":"2011","journal-title":"Emerg. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1128\/AAC.05760-11","article-title":"High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: Novel penA mosaic allele in a successful international clone causes treatment failure","volume":"56","author":"Unemo","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Day, M.J., Jacobsson, S., Spiteri, G., Kulishev, C., Sajedi, N., Woodford, N., Blumel, B., van der Werf, M.J., Amato-Gauci, A.J., and Unemo, M. (2022). Significant increase in azithromycin \u201cresistance\u201d and susceptibility to ceftriaxone and cefixime in Neisseria gonorrhoeae isolates in 26 European countries, 2019. BMC Infect. Dis., 22.","DOI":"10.1186\/s12879-022-07509-w"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.1128\/AAC.05143-14","article-title":"Effect of Variants of Penicillin-Binding Protein 2 on Cephalosporin and Carbapenem Susceptibilities in Neisseria gonorrhoeae","volume":"59","author":"Bharat","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/14737159.2022.2015329","article-title":"Antimicrobial resistance prediction in Neisseria gonorrhoeae: Current status and future prospects","volume":"22","author":"Golparian","year":"2022","journal-title":"Expert Rev. Mol. Diagn."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1128\/AAC.01604-06","article-title":"Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime and ceftriaxone: Association with genetic polymorphisms in penA, mtrR, porB1b, and ponA","volume":"51","author":"Lindberg","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrurol.2016.268","article-title":"Antimicrobial-resistant sexually transmitted infections: Gonorrhoea and Mycoplasma genitalium","volume":"14","author":"Unemo","year":"2017","journal-title":"Nat. Rev. Urol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Zapun, A., Morlot, C., and Taha, M.K. (2016). Resistance to \u03b2-Lactams in Neisseria ssp Due to Chromosomally Encoded Penicillin-Binding Proteins. Antibiotics, 5.","DOI":"10.3390\/antibiotics5040035"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1093\/jac\/dkq187","article-title":"Reduced susceptibility to ceftriaxone in Neisseria gonorrhoeae is associated with mutations G542S, P551S and P551L in the gonococcal penicillin-binding protein 2","volume":"65","author":"Whiley","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e02005-19","DOI":"10.1128\/AAC.02005-19","article-title":"Equations to Predict Antimicrobial MICs in Neisseria gonorrhoeae Using Molecular Antimicrobial Resistance Determinants","volume":"64","author":"Demczuk","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1093\/jac\/dkab308","article-title":"Prediction of ceftriaxone MIC in Neisseria gonorrhoeae using DNA microarray technology and regression analysis","volume":"76","author":"Shaskolskiy","year":"2021","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Allan-Blitz, L.T., Adamson, P.C., and Klausner, J.D. (2022). Resistance-Guided Therapy for Neisseria gonorrhoeae. Clin. Infect. Dis., ciac371.","DOI":"10.1093\/cid\/ciac371"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Zhao, L., Liu, A., Li, R., Zhang, Z., Jia, Y., and Zhao, S. (2022). High prevalence of blaTEM-135 and genetic epidemiology of blaTEM-135-carrying Neisseria gonorrhoeae isolates in Shandong, China, 2017\u20132019. J. Antimicrob. Chemother., dkac192.","DOI":"10.1093\/jac\/dkac192"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Shaskolskiy, B., Dementieva, E., Kandinov, I., Filippova, M., Petrova, N., Plakhova, X., Chestkov, A., Kubanov, A., Deryabin, D., and Gryadunov, D. (2019). Resistance of Neisseria gonorrhoeae isolates to beta-lactam antibiotics (benzylpenicillin and ceftriaxone) in Russia, 2015\u20132017. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0220339"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"896607","DOI":"10.3389\/fmicb.2022.896607","article-title":"In vitro susceptibility to \u03b2-Lactam antibiotics and viability of Neisseria gonorrhoeae strains producing plasmid-mediated broad- and extended-spectrum \u03b2-lactamases","volume":"13","author":"Kandinov","year":"2022","journal-title":"Front. Microbiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e452","DOI":"10.1016\/S2666-5247(22)00044-1","article-title":"Europe-wide expansion and eradication of multidrug-resistant Neisseria gonorrhoeae lineages: A genomic surveillance study","volume":"3","author":"Cole","year":"2022","journal-title":"Lancet Microbe"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1097\/OLQ.0000000000001303","article-title":"Characterization of 2 Neisseria gonorrhoeae Strains With High-Level Azithromycin Resistance Isolated in 2015 and 2018 in Japan","volume":"48","author":"Shimuta","year":"2021","journal-title":"Sex. Transm. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e0229421","DOI":"10.1128\/aac.02294-21","article-title":"Markedly Increasing Antibiotic Resistance and Dual Treatment of Neisseria gonorrhoeae Isolates in Guangdong, China, from 2013 to 2020","volume":"66","author":"Lin","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Zhou, Q., Liu, J., Chen, S., Xu, W., Han, Y., and Yin, Y. (2021). The Accuracy of Molecular Detection Targeting the Mutation C2611T for Detecting Moderate-Level Azithromycin Resistance in Neisseria gonorrhoeae: A Systematic Review and Meta-Analysis. Antibiotics, 10.","DOI":"10.3390\/antibiotics10091027"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e02281-18","DOI":"10.1128\/mBio.02281-18","article-title":"Mechanistic Basis for Decreased Antimicrobial Susceptibility in a Clinical Isolate of Neisseria gonorrhoeae Possessing a Mosaic-Like mtr Efflux Pump Locus","volume":"9","author":"Reimche","year":"2018","journal-title":"mBio"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1093\/jac\/dkw182","article-title":"Molecular epidemiology and mechanisms of resistance of azithromycin-resistant Neisseria gonorrhoeae isolated in France during 2013-14","volume":"71","author":"Belkacem","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"831336","DOI":"10.3389\/fcimb.2022.831336","article-title":"Comparative whole-genome analysis of Neisseria gonorrhoeae isolates revealed changes in the gonococcal genetic island and specific genes as a link to antimicrobial resistance","volume":"12","author":"Shaskolskiy","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jinf.2016.08.010","article-title":"Genomic analyses of Neisseria gonorrhoeae reveal an association of the gonococcal genetic island with antimicrobial resistance","volume":"73","author":"Harrison","year":"2016","journal-title":"J. Infect."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Lim, K.Y.L., Mullally, C.A., Haese, E.C., Kibble, E.A., McCluskey, N.R., Mikucki, E.C., Thai, V.C., Stubbs, K.A., Sarkar-Tyson, M., and Kahler, C.M. (2021). Anti-Virulence Therapeutic Approaches for Neisseria gonorrhoeae. Antibiotics, 10.","DOI":"10.3390\/antibiotics10020103"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1056\/NEJMoa1706988","article-title":"Single-Dose Zoliflodacin (ETX0914) for Treatment of Urogenital Gonorrhea","volume":"379","author":"Taylor","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/cid\/ciy145","article-title":"Gepotidacin for the Treatment of Uncomplicated Urogenital Gonorrhea: A Phase 2, Randomized, Dose-Ranging, Single-Oral Dose Evaluation","volume":"67","author":"Taylor","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S1473-3099(19)30116-1","article-title":"Solithromycin versus ceftriaxone plus azithromycin for the treatment of uncomplicated genital gonorrhoea (SOLITAIRE-U): A randomised phase 3 non-inferiority trial","volume":"19","author":"Chen","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/cid\/ciaa596","article-title":"Resistance-Guided Treatment of Gonorrhea: A Prospective Clinical Study","volume":"73","author":"Klausner","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"881392","DOI":"10.3389\/fcimb.2022.881392","article-title":"Recent Progress towards a Gonococcal Vaccine","volume":"12","author":"Maurakis","year":"2022","journal-title":"Front. Cell Infect. Microbiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0140-6736(17)31449-6","article-title":"Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: A retrospective case-control study","volume":"390","author":"Paynter","year":"2017","journal-title":"Lancet"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/cid\/ciy1061","article-title":"The serogroup B meningococcal vaccine Bexsero elicits antibodies to Neisseria gonorrhoeae","volume":"69","author":"Semchenko","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Semchenko, E.A., Day, C.J., and Seib, K.L. (2020). The Neisseria gonorrhoeae Vaccine Candidate NHBA Elicits Antibodies That Are Bactericidal, Opsonophagocytic and That Reduce Gonococcal Adherence to Epithelial Cells. Vaccines., 8.","DOI":"10.3390\/vaccines8020219"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Retchless, A.C., Kretz, C.B., Chang, H.Y., Bazan, J.A., Abrams, A.J., Norris Turner, A., Jenkins, L.T., Trees, D.L., Tzeng, Y.L., and Stephens, D.S. (2018). Expansion of a urethritis-associated Neisseria meningitidis clade in the United States with concurrent acquisition of N. gonorrhoeae alleles. BMC Genom., 19.","DOI":"10.1186\/s12864-018-4560-x"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1016\/S0140-6736(20)30913-2","article-title":"Meningococcal disease and sexual transmission: Urogenital and anorectal infections and invasive disease due to Neisseria meningitidis","volume":"395","author":"Ladhani","year":"2020","journal-title":"Lancet"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/cid\/cix215","article-title":"Large cluster of Neisseria meningiditis urethritis in Columbus, Ohio, 2015","volume":"65","author":"Bazan","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e20162452","DOI":"10.1542\/peds.2016-2452","article-title":"Meningococcal B vaccine failure with a penicillin-resistant strain in a young adult on long-term Eculizumab","volume":"140","author":"Parikh","year":"2017","journal-title":"Pediatrics"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/jac\/dkw400","article-title":"Emergence of meningococci with reduced susceptibility to third-generation cephalosporins","volume":"72","author":"Deghmane","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Custodio, R., Johnson, E., Liu, G., Tang, C.M., and Exley, R.M. (2020). Commensal Neisseria cinerea impairs Neisseria meningitidis microcolony development and reduces pathogen colonisation of epithelial cells. PLoS Pathog., 16.","DOI":"10.1371\/journal.ppat.1008372"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.chom.2019.07.003","article-title":"Commensal Neisseria kill Neisseria gonorrhoeae through a DNA-dependent mechanism","volume":"26","author":"Kim","year":"2019","journal-title":"Cell Host Microbe"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"577762","DOI":"10.3389\/fmicb.2020.577762","article-title":"The Human Microbiome as a Focus of Antibiotic Discovery: Neisseria mucosa Displays Activity Against Neisseria gonorrhoeae","volume":"11","author":"Aho","year":"2020","journal-title":"Front. Microbiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e63755","DOI":"10.7554\/eLife.63755","article-title":"Type VI secretion system killing by commensal Neisseria is influenced by expression of type four pili","volume":"10","author":"Custodio","year":"2021","journal-title":"eLife"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Zommiti, M., Feuilloley, M.G.J., and Connil, N. (2020). Update of Probiotics in Human World: A Nonstop Source of Benefactions till the End of Time. Microorganisms, 8.","DOI":"10.3390\/microorganisms8121907"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/OLQ.0b013e31815b017a","article-title":"Probiotics: Potential to prevent HIV and sexually transmitted infections in women","volume":"35","author":"Bolton","year":"2008","journal-title":"Sex. Transm. Dis."}],"container-title":["Microorganisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2607\/10\/9\/1699\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:14:26Z","timestamp":1760141666000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2607\/10\/9\/1699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,24]]},"references-count":50,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["microorganisms10091699"],"URL":"https:\/\/doi.org\/10.3390\/microorganisms10091699","relation":{},"ISSN":["2076-2607"],"issn-type":[{"value":"2076-2607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,24]]}}}